A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)
NCT02130362
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
1446
Enrollment
INDUSTRY
Sponsor class
Conditions
Crohn's Disease
Sponsor
AbbVie